Latest Ratios: P/E Ratio -0.2x · EV/EBITDA N/A · ROE -34.4%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $43M | $25M | $9M | $5M | $184M | $253M | — | — | — |
| Enterprise Value | $28M | $10M | $10M | $5M | $187M | $245M | — | — | — |
| P/E Ratio → | -0.22 | — | — | — | — | — | — | — | — |
| P/S Ratio | 18.53 | 10.74 | 326.96 | 301.42 | — | — | — | — | — |
| P/B Ratio | 0.04 | 0.13 | 1.42 | 0.57 | 17.44 | 31.61 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.13 | 364.41 | 316.86 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.9% | 38.9% | -110.9% | 16.6% | — | — | — | — | — |
| Operating Margin | -676.1% | -676.1% | -21677.1% | -56443.7% | — | — | — | — | — |
| Net Profit Margin | -1418.1% | -1418.1% | -61248.0% | -72066.9% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -34.4% | -34.4% | -221.8% | -122.8% | -138.8% | -141.3% | -146.5% | -346.5% | — |
| ROA | -32.3% | -32.3% | -115.7% | -59.8% | -76.6% | -87.8% | -83.3% | -222.8% | -1224.8% |
| ROIC | -13.3% | -13.3% | -54.3% | -61.0% | -145.8% | -986.4% | -310.3% | -1071.4% | — |
| ROCE | -16.4% | -16.4% | -64.8% | -66.1% | -105.2% | -127.0% | -151.0% | -346.5% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.24 | 0.48 | 0.52 | 0.01 | 0.02 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.08 | 0.16 | 0.03 | 0.31 | -0.97 | -0.44 | -0.72 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -9.16 | -9.16 | -4.33 | -0.47 | -2.79 | -12.74 | — | — | — |
Net cash position: cash ($22M) exceeds total debt ($7M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.19 | 4.19 | 0.30 | 0.70 | 0.54 | 3.55 | 0.45 | 1.68 | 0.74 |
| Quick Ratio | 4.19 | 4.19 | 0.24 | 0.69 | 0.44 | 3.44 | 0.37 | 1.68 | 0.52 |
| Cash Ratio | 2.77 | 2.77 | 0.11 | 0.64 | 0.42 | 3.40 | 0.34 | 1.57 | 0.30 |
| Asset Turnover | — | 0.01 | 0.00 | 0.00 | — | — | — | — | — |
| Inventory Turnover | — | — | 0.21 | 0.35 | — | — | — | — | — |
| Days Sales Outstanding | — | 11.74 | 2601.22 | 691.82 | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.6% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.6% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $1M | $33943 | $967 | $301 | $253 | $242 | $242 | $27 |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AVX stock.
Avax One Technology Ltd's current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Avax One Technology Ltd's return on equity (ROE) is -34.4%. The historical average is -164.6%.
Based on historical data, Avax One Technology Ltd is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Avax One Technology Ltd has 38.9% gross margin and -676.1% operating margin.
Key Metrics
Top Statement Risk
Unsustainable Operating Burn Rate
Metrics are mathematically derived from official filings.
Speculative Premium Over Operational Reality
Based on reported figures, AVX trades at a price-to-sales multiple of 22.15, which appears to price in significant future commercial success rather than current earnings, as the company lacks a positive P/E ratio and remains in a deep, venture-stage development phase relative to its agricultural peers.
The elevated P/S ratio suggests that investors are valuing the company's intellectual property and potential market disruption rather than its current $2.3M revenue base. This valuation warrants caution, as it implies a high growth trajectory that may be difficult to sustain without further dilutive financing or a rapid pivot to profitability.
Gross Margin Volatility Hinders Scalability
According to recent quarterly filings, AVX's gross margin of 42.2% in 2026Q1 demonstrates the potential for profitability, yet the historical inconsistency of these margins suggests that the company has not yet achieved a stable cost structure for its specialized sterilization technology implementation.
While the 42.2% gross margin is encouraging for an IP-heavy model, the operating margin of -676.11% indicates that corporate overhead and R&D spending are currently overwhelming the gross profit generated. Investors should monitor whether the company can achieve operating leverage as it scales, or if its cost structure remains inherently tied to high-burn development activities.
Capital Erosion Reflects Early-Stage Risk
As reported in financial statements, the company's ROIC of -0.7% in 2026Q1 highlights a persistent inability to generate positive returns on invested capital, a trend that is consistent with its current phase of aggressive, loss-making expansion into the controlled environment agriculture market.
The negative ROIC suggests that the capital deployed into the business is currently destroying value rather than compounding it. Until the company can demonstrate a path to positive returns, the current capital allocation strategy appears to be focused on survival and market entry rather than efficient wealth creation for shareholders.
Working Capital Inefficiency Strains Liquidity
Based on the provided data, the company's asset turnover ratio of 0.01 in 2026Q1 indicates an extremely low level of operational efficiency, suggesting that the firm's asset base is not yet being utilized effectively to drive meaningful revenue growth relative to its total capital investment.
The high DSO and volatile CCC metrics suggest that the company faces challenges in converting its project-based engagements into timely cash inflows. This inefficiency, combined with the project-based nature of its revenue, may lead to significant liquidity pressure if the company cannot shorten its collection cycles.
Misapplication of Traditional Agricultural Metrics
Investors frequently misapply traditional agricultural valuation ratios to AVX, failing to recognize that the company functions as a technology-driven IP firm, which renders standard metrics like P/B or P/E less relevant than assessing the company's cash burn runway and the commercial viability of its patents.
Using traditional agricultural sector benchmarks obscures the reality that AVX is a venture-stage entity with a high-risk, high-reward profile. Analysts should instead focus on the 'Cash Burn to Revenue' ratio and the rate of IP commercialization to better gauge the company's true fundamental health and long-term potential.